Industry News
University of Otago and GE Healthcare partner on medical imaging
Medical technology company GE Healthcare has signed a partnership agreement with the University of Otago's Centre for Bioengineering & Nanomedicine to work together on medical imaging technology projects. [ + ]
Algorithm to catch nuclear traffickers
A US research team has discovered that coupling commercially available spectral X-ray detectors with a specialised algorithm can improve the detection of uranium and plutonium in small, layered objects such as baggage. [ + ]
Coastal research centre for China and New Zealand
The University of Waikato has signed an agreement with the Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, to establish a coastal biotechnology research centre. With bases in both Tauranga and China, the China-New Zealand Coastal Biotechnology Joint Research Centre would aim to integrate China and New Zealand's coastal biotechnology research experts. [ + ]
CNS to help plan pancreatic cancer trial
CNS has secured a deal to provide clinical and regulatory services for a Nuvilex pancreatic cancer treatment candidate, including planning for an Australian phase IIb trial. [ + ]
Collision in pitch drop experiment
The University of Queensland's (UQ) pitch drop experiment marked a milestone last week as the ninth drop of pitch slowly collided with the eighth drop in the bottom of the beaker. [ + ]
Funding for prostate cancer research
Funding is available for translational research in prostate cancer. [ + ]
AusBiotech to submit to Senate's 'Australian innovation system' inquiry
AusBiotech is preparing a submission following the Senate's referral of an inquiry into Australia's innovation system to the Senate Economics References Committee for inquiry and report. [ + ]
ResMed launches two new AirFit masks
ResMed (ASX:RMD) has added a new nasal mask and a full-face mask to its AirFit line of sleep-disordered breathing therapy devices. [ + ]
The evolution of chloroquine
A different way of administering chloroquine could see its renewed use to treat malaria. [ + ]
Drawbridge anaesthetic beats propofol during trial
Drawbridge Pharmaceuticals announced that anaesthesia candidate Phaxan outperformed the SOC propofol during the first in-human trial comparing the two drugs. [ + ]
Queensland Government to inject $1m into MRCF
The Queensland Government will kick another $1m into the Medical Research Commercialisation Fund (MRCF), a VC fund jointly supported by the federal, Qld, Vic, NSW and WA governments. [ + ]
Chemical cues direct sperm in healthier choice
Cues given off by unfertilised female mussel eggs act as a genetically compatible chemoattractant to sperm. [ + ]
TGA's low value turnover exemption scheme under review
The Therapeutic Goods Administration (TGA) has announced a review of the low value turnover exemption scheme (LVT scheme), which exempts cost recovery fees on products with low turnover. [ + ]
Nexvet raises $33.6m in financing round
Nexvet Biopharma will put the proceeds of a $33.6m Series B financing round to funding key clinical trials for its lead products, as well as expanding its development pipeline and US presence. [ + ]
Innate to start recruiting for SPMS trial in June
Innate Immunotherapeutics (ASX:IIL) expects to start recruiting up to 90 secondary progressive multiple sclerosis patients for a phase IIb trial of MIS416 in June. [ + ]
